Поисковый запрос: (<.>S=ФАРМАКОГЕНОМИКА<.>) |
Общее количество найденных документов : 71
Показаны документы с 1 по 20
|
|
1.
| Hodge A.E. The PharmGKB: Integration, aggregation, and annotation of pharmacogenomic data and knowledge // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 1.-С.21-24
|
2.
| Licinio Pharmacogenomics of neuroimmune interactions in human psychiatric disorders // Exp. Physiol., 2007. Vol. 92, N 5.-С.807-811
|
3.
| Hodge A.E. The PharmGKB: Integration, aggregation, and annotation of pharmacogenomic data and knowledge // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 1.-С.21-24
|
4.
| Influence of the CYP2D6{*}4 polymorphism on dose, switching and discontinuation of antidepressants // Brit. J. Clin. Pharmacol., 2008. Vol. 65, N 4.-С.558-564
|
5.
| Микрочипы и исследование китайских лекарственных препаратов: фармакогеномика китайских лекарственных препаратов // Zhongguo zhongyao zazhi, 2007. Vol. 32, N 4.-С.289-292
|
6.
| Лути-Картер Р. Фармакогеномное выявление потенциальных путей нейропротекции при болезни Гентингтона // Эксперим. и клин. фармакол., 2010, Прил..-С.7
|
7.
| Hodge A.E. The PharmGKB: Integration, aggregation, and annotation of pharmacogenomic data and knowledge // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 1.-С.21-24
|
8.
| Pharmacogenomics: A new paradigm to personalize treatments in nephrology patients // Clin. and Exp. Immunol., 2010. Vol. 159, N 3.-С.268-280
|
9.
| Relling M.V. Should pharmacogenomic studies be required for new drug approval? // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 3.-С.425-428
|
10.
| Apports de la pharmacogenomique et de la pharmacogenetique dans les cancers digestifs // Oncologie, 2005. Vol. 7, N 8.-С.619-625
|
11.
| Patrinos George P. Pharmacogenomics and therapeutics of hemoglobinopathies // Hemoglobin, 2008. Vol. 32, N 1-2.-С.229-236
|
12.
| Biason P. UGT1A1{*} 28 and other UGT1A polymorphisms as determinants of irinotecan toxicity // J. Chemother., 2008. Vol. 20, N 2.-С.158-165
|
13.
| Apports de la pharmacogenomique et de la pharmacogenetique dans les cancers digestifs // Oncologie, 2005. Vol. 7, N 8.-С.619-625
|
14.
| The pharmacogenetics research network: From SNP discovery to clinical drug response // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 3.-С.328-345
|
15.
| Nguyen A. Enhancing race-based prescribing precision with phamacogenomics // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 3.-С.323-325
|
16.
| Owen Ryan P. PharmGKB and the international warfarin pharmacogenetics consortium: The changing role for pharmacogenomic databases and single-drug pharmacogenetics // Hum. Mutat., 2008. Vol. 29, N 4.-С.456-460
|
17.
| Fuhr U. Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "Cocktail" approach // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 2.-С.270-283
|
18.
| Kroetz D.L. The pharmacogenomics of membrane transporters project: Research at the interface of genomics and transporter pharmacology // Clin. Pharmacol. and Ther., 2010. Vol. 87, N 1.-С.109-116
|
19.
| Ritchie Marylyn D. The success of pharmacogenomics in moving genetic association studies from bench to bedside: Study design and implementation of precision medicine in the post-GWAS era // Hum. Genet., 2012. Vol. 131, N 10.-С.1615-1626
|
20.
| Полиморфизмы генов, кодирующих транспортеры лекарственных средств ABCB1 и ABCG2, и исследование их методом пиросеквенирования // Эксперим. и клин. фармакол., 2012. Т. 75, N 10.-С.29-36
|
&uf('+1W2226#',v2226), ?>
|
|